Skip to content

Gastric Preparation of Magnetic-controlled Capsule Endoscopy

Gastric Preparation of Magnetic-controlled Capsule Endoscopy: A Prospective, Single Blinded and Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02846155
Enrollment
120
Registered
2016-07-27
Start date
2016-05-31
Completion date
2016-12-31
Last updated
2016-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach Diseases

Keywords

preparation, capsule endoscopy

Brief summary

By using three different Gastric Preparation of Magnetic-controlled Capsule Endoscopy, the investigators hope to find out the optimal gastric preparation plan.

Detailed description

It is a prospective, single-blind, randomized controlled trial. Patients who were conducted by Magnetic-controlled Capsule Endoscopy at Changhai Hospital will be randomly allocated into three different Gastric Preparation group before the procedure. It include clear water group which patient only drink 1000ml clear water before checking; simethicone group which patient drink 950ml clear water and 15ml simethicone before checking; simethicone combined with pronase group which patient drink 900ml lear water and 15ml simethicone and 20,000iu pronase before checking. The result were got from a relevant professional physician's blinded independent image-reading.

Interventions

OTHERclear water

the patients just drink common clear water before Magnetic-controlled Capsule Endoscopy examination

the patients drink clear water and simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion) before Magnetic-controlled Capsule Endoscopy examination

DRUGsimethicone combined with pronase

the patients drink simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion),pronase granules(Deyou;Beijing Tide Pharmaceutical Co,China,containing 20,000iu pronase),and clear water before Magnetic-controlled Capsule Endoscopy examination

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult patients aged 16-75 years, who were scheduled to undergo a Magnetic-controlled Capsule Endoscopy, were eligible for this study.

Exclusion criteria

* Dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, overt gastrointestinal bleeding, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy, or postabdominal radiation; * Congestive heart failure, renal insufficiency, under therapeutic anticoagulation, in poor general condition (American Society of Anesthesiologists class III/IV), claustrophobia, metallic parts, a pacemaker or other implanted electromedical devices, artificial heart valves; * Pregnancy or suspected pregnancy; *

Design outcomes

Primary

MeasureTime frameDescription
the level of gastric cleansing4 monthTwo investigators who did not know which kind of gastric preparation of the patient scored the level of gastric cleansing 0f 120 participants according to a four-point grading scale: poor, fair, good, and excellent,which was pointed 3,2,1,and 0.The investigators should evaluate the gastric cleansing of six anatomical landmarks (cardia, fundus, body, angulus, antrum and pylorus).A poor level of cleansing indicated the mucosa was obscured largely by a lot of air bubbles and grume,fair indicated that a portion of the mucosa was obscured by air bubbles and grume that was enough to prevent a reliable visualization of polyps, good indicated that a small amount of air bubbles and grume,and excellent indicated that the fluid was clear and the image was either free or had only small bits of air bubbles and grume.

Secondary

MeasureTime frameDescription
Diagnostic yield of Magnetic-controlled Capsule Endoscopy4 monthThe gastric focal lesion was defined as any of the positive findings including polyp, ulcers, submucosal tumor (SMT) and others (i.e. xanthoma, diverticulum, etc.). Erosion, gastritis and gastric atrophy were defined as negative findings, because they are diffuse lesions which can be easily diagnosed by Magnetic-controlled Capsule Endoscopy.
Tolerability of participants4 monthThe endoscopist scored the tolerability of participants according to a three-point grading scale: poor, fair, and excellent,which was pointed 2,1,and 0.A poor tolerability of participants indicated patients with perforated severe abdominal pain,nausea, vomiting,etc.fair indicated patients with perforated little abdominal pain,nausea, vomiting.and excellent indicated that patients with no obvious discomfort.
Transit time4 monthinclude gastric transit time,smal bowel transit time
the time of gastric examination4 monththe time indicated since the first gastric mucosal image was observed to the endoscopist completed the whole gastric examination。
the added amount of water of the whole process during gastric examination4 month
the visibility of gastric4 monthTwo investigators scored the level of gastric visibility 0f 120 participants according to a four-point grading scale: poor, fair, good, and excellent,which was pointed 3,2,1,and 0.The investigators should evaluate the visibility of gastric of six anatomical landmarks (cardia, fundus, body, angulus, antrum and pylorus).A poor level of cleansing indicated the less than 50% of mucosa could be seen,fair indicated that 50%-75% of the mucosa could be seen, good indicated that more than 75% of the mucosa could be seen,and excellent indicated the whole mucosa could be seen.

Countries

China

Contacts

Primary ContactZhuan Liao
liaozhuan@smmu.edu.cn

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026